产品详情
靶点信息
VEGFR2 | Flk1 | FGFR1 | VEGFR1 | |
25 nM | 89 nM | 148 nM | 380 nM |
In vitro (25°C) | DMSO | 83 mg/mL (188 mM) | |
Water | Insoluble | ||
Ethanol | 83 mg/mL (188 mM) | ||
In vivo | 0.5% methylcellulose+0.2% Tween 80 | 9 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 22.65 mL | 113.25 mL | 226.5 mL |
0.5 mM | 4.53 mL | 22.65 mL | 45.3 mL |
1 mM | 2.27 mL | 11.33 mL | 22.65 mL |
5 mM | 0.45 mL | 2.27 mL | 4.53 mL |
*The above data is based on the productmolecular weight 441.5. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10162 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 441.5 |
Formula | C22H24FN5O4 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 649735-63-7 |
Synonyms | BMS582664 |
SMILES | CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NN4C3=C(C(=C4)OC[C@@H](C)OC(=O)[C@H](C)N)C |
产品资料
产品标签
Product Questions
Product Questions
Vandetanib (ZD6474)
Vandetanib (ZD6474)是一种VEGFR和EGFR拮抗剂,是一种酪氨酸激酶抑制剂,对于HUVEC增殖,PC-9细胞和酪氨酸激酶活…
Apatinib (YN968D1)
Apatinib (YN968D1)是一种酪氨酸激酶抑制剂,可选择性抑制血管内皮生长因子受体2(VEGFR2,也称为KDR),后者…
Motesanib (AMG706)
Motesanib(AMG706)是一种多激酶抑制剂,可选择性靶向VEGF受体,血小板衍生的生长因子受体(PDGFRs)和Kit受体…
TSU-68 (Orantinib, SU6668)
TSU-68 (Orantinib,SU6668)在无细胞试验中具有8 nM的Ki对PDGFR自磷酸化的最大效力,但也强烈抑制Flk-1和FGFR1反磷酸…
BMS-690514
BMS-690514是一种有效的选择性表皮生长因子受体(EGFR),HER2和HER4抑制剂,以及VEGF受体激酶。
Regorafenib (BAY 73-4506)
Regorafenib (BAY 73-4506)是一种多激酶抑制剂,IC50为17、40和69 nM c-KIT,VEGFR2,B-Raf。Regorafenib(BAY 73-4506)是一种…
Raf265 derivative
Raf265 derivative是Raf265的衍生物,Raf265是一种口服,高度选择性的RAF和VEGFR激酶抑制剂,IC50为5至10μM。